Ep 177: Ross Haber: Trusting The Follow-Through Day
Investing With IBD
00:00
The Fundamentals of a Biotech Position
The company has a 24% EPS growth rate with an earnings stability of three, you know, so meaning very stable earnings. Is the fundamentals coming into this picture at all, or are you just really kind of focused on the technical? Oh, no, the fun. I mean, that wouldn't get the fun. It wouldn't make it on my top 10 as well if it wasn't for the fundamentals. That's what gives me confidence to hold a position in anything.
Transcript
Play full episode
